Rhizoma coptidis as a Potential Treatment Agent for Type 2 Diabetes Mellitus and the Underlying Mechanisms: A Review
- PMID: 31396083
- PMCID: PMC6661542
- DOI: 10.3389/fphar.2019.00805
Rhizoma coptidis as a Potential Treatment Agent for Type 2 Diabetes Mellitus and the Underlying Mechanisms: A Review
Abstract
Diabetes mellitus, especially type 2 diabetes mellitus (T2DM), has become a significant public health burden. Rhizoma coptidis (RC), known as Huang Lian, is widely used for treating diabetes in China. The bioactive compounds of RC, especially alkaloids, have the potential to suppress T2DM-induced lesions, including diabetic vascular dysfunction, diabetic heart disease, diabetic hyperlipidemia, diabetic nephropathy, diabetic encephalopathy, diabetic osteopathy, diabetic enteropathy, and diabetic retinopathy. This review summarizes the effects of RC and its bioactive compounds on T2DM and T2DM complications. Less research has been conducted on non-alkaloid fractions of RC, which may exert synergistic action with alkaloids. Moreover, we summarized the pharmacokinetic properties and structure-activity relationships of RC on T2DM with reference to extant literature and showed clearly that RC has potential therapeutic effect on T2DM.
Keywords: Huang Lian; Rhizoma coptidis; complications; ethnopharmacology; type 2 diabetes mellitus.
Figures






Similar articles
-
Rhizoma Coptidis: A Potential Cardiovascular Protective Agent.Front Pharmacol. 2016 Oct 7;7:362. doi: 10.3389/fphar.2016.00362. eCollection 2016. Front Pharmacol. 2016. PMID: 27774066 Free PMC article. Review.
-
Comparative Pharmacokinetic Profiles of Three Protoberberine-type Alkaloids from Raw and Bile-processed Rhizoma coptidis in Heat Syndrome Rats.Pharmacogn Mag. 2017 Jan-Mar;13(49):51-57. doi: 10.4103/0973-1296.197632. Pharmacogn Mag. 2017. PMID: 28216883 Free PMC article.
-
Effect of Rhizoma coptidis (Huang Lian) on Treating Diabetes Mellitus.Evid Based Complement Alternat Med. 2015;2015:921416. doi: 10.1155/2015/921416. Epub 2015 Oct 5. Evid Based Complement Alternat Med. 2015. PMID: 26508987 Free PMC article. Review.
-
Cellular stress response mechanisms of Rhizoma coptidis: a systematic review.Chin Med. 2018 Jun 7;13:27. doi: 10.1186/s13020-018-0184-y. eCollection 2018. Chin Med. 2018. PMID: 29930696 Free PMC article. Review.
-
Pharmacokinetics of Five Alkaloids and their Metabolites in Normal and Diabetic Rats after Oral Administration of Rhizoma coptidis.Planta Med. 2022 Sep;88(11):921-932. doi: 10.1055/a-1506-1627. Epub 2021 Jun 10. Planta Med. 2022. PMID: 34111890
Cited by
-
Huanglian-Renshen-Decoction Maintains Islet β-Cell Identity in T2DM Mice through Regulating GLP-1 and GLP-1R in Both Islet and Intestine.Chin J Integr Med. 2025 Jan;31(1):39-48. doi: 10.1007/s11655-024-3915-1. Epub 2024 Nov 18. Chin J Integr Med. 2025. PMID: 39551849
-
Mechanism of action of Coptidis Rhizome in treating periodontitis based on network pharmacology and in vitro validation.BMC Oral Health. 2024 May 4;24(1):530. doi: 10.1186/s12903-024-04311-9. BMC Oral Health. 2024. PMID: 38704553 Free PMC article.
-
Physiological and Pathological Roles of Aldose Reductase.Metabolites. 2021 Sep 27;11(10):655. doi: 10.3390/metabo11100655. Metabolites. 2021. PMID: 34677370 Free PMC article. Review.
-
Comprehensive analysis of the complete mitochondrial genomes of three Coptis species (C. chinensis, C. deltoidea and C. omeiensis): the important medicinal plants in China.Front Plant Sci. 2023 May 29;14:1166420. doi: 10.3389/fpls.2023.1166420. eCollection 2023. Front Plant Sci. 2023. PMID: 37313257 Free PMC article.
-
The potential role and mechanism of Rhizoma Coptidis in prevention of diabetic encephalopathy: targeting sodium ion and channels.Front Pharmacol. 2025 Mar 14;16:1542015. doi: 10.3389/fphar.2025.1542015. eCollection 2025. Front Pharmacol. 2025. PMID: 40160459 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources